Par Pharmaceutical Companies, Inc.has announced that it's partner, Genpharm Inc.of Toronto, Canada, has received final approval from the FDA for its Abbreviated New Drug Application for pravastatin 10... Related Results Statins decrease risk of colon cancer: study DuPont to Sell Pharmaceutical Unit to Bristol-Myers Squibb for $7. 8 Billion. Statins start to scatter in different directions First Data to Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam... play pot of gold superball keno free casino mpeg downloads chicago gambling during the1970 money line casino